Novotech Joins Decentralized Trials & Research Alliance (Dtra) To Democratize And Accelerate Clinical Trials
Hong Kong – July 20th , 2021 – Novotech Health Holdings Pte. Ltd.
Novotech expands virtual clinical trials capabilities
NEW YORK – July 1, 2021 - ObvioHealth, a global Virtual Research Organization (VRO), announces it has raised $31 million
Novotech Certified as a Great Workplace by Global Authority on Workplace Culture for Second Consecutive Year
Sydney - Australia – Novotech, the largest biotech specialist CRO in the Asia-Pacific region, has again been certified a
Starting Your Clinical Journey With The End In Mind – The Value Of A Drug Development Plan
Establishing an intelligent clinical development program pathway from the start is vital for clarity around the complex processes require
Celebrating International Day for Women and Girls in Science 2021
Thursday 11 February 2021
Novotech Health Holdings Appoints Andy Liu as Head of China
SHANGHAI and SYDNEY, Jan.
Novotech South Korea Celebrates 100th Employee as Biotechs Turn to the Asia-Pacific for Study Continuity
A leading Asia-Pacific biotech specialist CRO Novotech celebrates its 100th employee appointment at the Seoul, South Korea office.
Novotech Health Holdings Appoints Zidong Zhang as CFO
SHANGHAI and SYDNEY, 29 December 2020 – Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist c
An end of year message from Novotech CEO John Moller
Dear customers, partners and colleagues, I want to start by acknowledging how difficult this year has been for many people and
Novotech Health Holdings, Anand Tharmaratnam 이사회 의장 임명 발표
2020년 12월 8 일 상하이 및 시드니 – 아시아 최대 생명공학 임상시험수탁기관(CRO)인 Novotech Health Holdings (“Novotech Holdings”)는 Anand Tharmaratnam을
Novotech and PPC Group Announce Merger to Form Novotech Health Holdings
Combined company will create largest specialist biotech CRO platform in Asia to meet the rapidly growing demand for quality clinical